R&D Drug Pipeline Database: 1-Year Subscription Now available via MarketResearchReports.com

R&D Drug Pipeline Database provides online access to more than 17,000 project entries in all therapeutic areas and product categories. Each project is specified for its Target or Mechanism of Action, Product Category, Therapeutic Area, indication and R&D Phase. Use of the R&D database of marketed and investigational drugs is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major products are provided. The projects can be segmented into Therapeutic Areas, Territories, Product Categories and R&D Phases. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column headers, projects can be arranged and listed/displayed in ascending or descending alphabetical or numerical order, e.g. for R&D phase, product category or company name.

Purchase of the subscription provides a 1-year online access to the data of the R&D Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase and e-mail support will be provided.

Benefits from the R&D Drug Pipeline Database:

• Intuitive use
• Designed for structured searches
• Focused on targets, product categories and R&D phases
• Ideal for competitor analysis (companies, targets, product categories)
• Cost-effective and rapid solution for benchmarking
• Identification of licensing candidates

Project listing in a tabular format:

• Drug Codes
• Target / Mechanism of Action
• Class of Compound
• Product Category
• Company
• Territory
• Therapeutic Area
• Indication
• R&D Phase

Product Categories:

• Antibody
• Cell
• DNA
• Medical Device / Biomaterial
• Peptide
• Protein
• Radiopharmaceutical
• RNA
• Small Molecule
• Vaccine

Therapeutic Areas:-

• Cardiovascular, blood & acute care
• Dermatology
• Gastrointestinal
• Genitourinary, gynecology & renal
• Infectious & toxicology
• Metabolism & endocrine
• Neurology & psychiatry
• Oncology
• Ophthalmolgoy & otorhinolaryngology
• Orthopedics, dental, anesthesia & surgery
• Pulmonary & respiratory
• Rheumatoid & autoimmune

Examples of Predefined Targets of the Scroll Down Menu:

• Anti-Infective Antibodies
• Antibody-Drug Conjugates (ADC)
• Biologic & Immune Therapy of S. aureus Infections
• c-MET/HGF Inhibitors
• CD20 Antibodies
• Coagulation Factors
• CXCR and CXCL Agonists & Antagonists
• Dengue Virus Vaccines
• EGF-R Agonists and Antagonists
• Enzyme Replacement Therapies
• Erythropoiesis Stimulating Agents
• G-CSF and GM-CSF
• HDAC Inhibitors
• HDL Raising Therapies
• Heat shock protein 90 (Hsp90) Inhibitors
• HPV Vaccines
• Human Growth Hormone
• IGF-1R Antagonists
• Insulin
• Interferon
• Interleukin-17 and IL-17R Antagonists
• Janus Kinase (JAK) Inhibitors
• Malaria Vaccines
• NGF Agonists & Antagonists
• Novel Mitotic Kinase Inhibitors
• PDGF-R Agonists and Antagonists
• PI3K-AKT-mTOR Inhibitors
• Ras-Raf-MEK-ERK Inhibitors
• Targeted Therapy of Hepatitis C
• TGF-R Agonists and Antagonists
• TNF Agonists & Antagonists
• Toll-Like Receptor (TLR) Agonists and Antagonists
• VEGF and VEGF-R Agonists and Antagonists

For more information visit: http://www.marketresearchreports.com/la-merie-publishing/rd-drug-pipeline-database-1-year-subscription

Find all Research and Development (Pharma & Healthcare) reports under a single page

MarketResearchReports.com: Patient Monitoring and Diagnostic Systems Markets in China, New Report Launched

China's demand for patient monitoring and diagnostic systems has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.

Spanning over 176 pages, 5 table and 5 charts, “Patient Monitoring and Diagnostic Systems Markets in China” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the Business Environment, Patient monitoring and Diagnostic systems industry assessments, Patient monitoring and Diagnostic systems sales volumes and sales forecasts, Patient monitoring and Diagnostic systems market outlook, Marketing Strategies, Patient Monitoring and Diagnostic Systems Producer Directory.

For more information visit: http://www.marketresearchreports.com/asia-market-information-development-co/patient-monitoring-and-diagnostic-systems-markets-china

Find all Medical Devices reports under a single page at:

MarketResearchReports.com: Medical Imaging System and Equipment Markets in China, New Report Launched

China's demand for medical imaging system and equipment has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.

Spanning over 180 pages, 5 table and 5 charts, “Medical Imaging System and Equipment Markets in China” report provides information on market overview, drivers and challenge, competition and key trends. For more information visit: http://www.marketresearchreports.com/asia-market-information-development-co/medical-imaging-system-and-equipment-markets-china

In addition to covering the Business Environment, Medical imaging system and Equipment industry assessments, Medical imaging system and Equipment sales volumes and sales forecasts, Medical imaging system and Equipment market outlook, Marketing strategies, Medical imaging system and Equipment producer directory.

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: Hearing Aids Markets in China, New Report Launched

China's demand for hearing aids has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.

Spanning over 167 pages, 5 table and 5 charts, “Hearing Aids Markets in China” report provides information on market overview, drivers and challenge, competition and key trends. For more information visit: http://www.marketresearchreports.com/asia-market-information-development-co/hearing-aids-markets-china 

In addition to covering the Business Environment, Hearing Aids Industry Assessments, Hearing aids Sales Volumes and Sales Forecasts, Hearing Aids Market Outlook, Marketing Strategies, Hearing Aids Producer Directory.

Find all Medical Devices reports under a single page at: http://www.marketresearchreports.com/medical-devices

MarketReserachReports.com: The Global Ostomy Drainage Bags Market to Reach $3.1 billion by 2019, Reveals New Report

The global ostomy drainage bags market is forecast to increase from $2.2 billion in 2012 to $3.1 billion by 2019, at a Compound Annual Growth Rate (CAGR) of 5%, finds new report.

According to the company’s latest ” Ostomy Drainage Bags Market to 2019 - Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential” report, the increasing prevalence of conditions such as colorectal cancer, inflammatory bowel disease and prostate cancer, which require surgery and the creation of a fecal or urinary stoma, is the major driver for the forecast growth.

In 2012, three top companies accounted for more than 80% of the global market, with Coloplast, Convatec and Hollister having shares of 37%, 28% and 17%, respectively.

Technical advances in ostomy bags will also be a major driver for growth during the forecast period.

Report’s lead Analyst covering Medical Devices, says: “In addition to progress in urinary and fecal diversions, complications such as morbidity associated with radical pelvic surgery and major surgical procedures have massively reduced. Other significant advances include the improved ability to identify autonomic nerves, while increased use of laparoscopy reduces the risk of post-operative morbidity and recovery time.”

However, the unfavorable reimbursement scenario for ostomy drainage bags in developed countries is expected to limit future growth. In the US, inadequate reimbursement encourages ostomates to prolong the usage of ostomy drainage bags beyond their average lifetime, which limits demand for new ones. In Europe, many countries, with the exception of Germany and France, do not have fixed reimbursement fees for the procedure.

“In 2012, Eucomed, an association of various stakeholders in the medical device industry, announced proposals to address the challenges in the reimbursement provided for ostomy. These non-profit associations, combined with companies pushing for better reimbursement scenarios, are vital for the future growth of the ostomy drainage bags market,” says analyst.

In countries such as India and China, there is currently no reimbursement for ostomy surgeries, and a lack of awareness of this issue could be a major restraint to companies expanding into these under-penetrated markets.

This report looks at the market, key market players, and market dynamics for the global ostomy drainage bags market. It provides a synopsis of the various factors influencing this market. This report also gives company descriptions and lists the key marketed products for major market players.

Spanning over 48 pages, 33 tables and 30 figures, “Ostomy Drainage Bags Market to 2019 - Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the Global Ostomy Drainage Bags Market: Device Overview, Global Ostomy Drainage Bags Market: Market Characterization, Global Ostomy Drainage Bags Market: Country-Wise Revenue (2005–2019), Global Ostomy Drainage Bags Market: Company Profiles. The report covers 5 companies - Coloplast A/S, ConvaTec Inc., Hollister Incorporated, Dansac A/S, B. Braun Melsungen AG.

Find all Medical Devices market research reports under a single page.

Asia Pacific Solid Tumors Market to Reach $2.3 Billion by 2019, Reveals New Report

The Asia-Pacific solid tumors treatment markets – bladder, ovarian, pancreatic and prostate cancers – is expected to grow from $1 billion in 2012 to $2.3 billion in 2019, at a Compound Annual Growth Rate (CAGR) of 12.3%, forecasts new business report.

According to the company’s latest “ Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies " report, the fastest growing market for solid tumors in the Asia-Pacific region is Australia, achieving an expected CAGR of 13.9% by the end of the forecast period. A slower growth rate is expected in India (9.7%) and China (5.5%), due primarily to stricter pricing regulations and recent price cuts.

The average cost of treatment for the four cancer types mentioned previously is also estimated to grow from $4,001 in 2012 to $6212.5 by 2019, at a CAGR of 6.5%. The cost of treatment in Australia will be even higher, increasing from $3,703 in 2012 to $7,576 by 2019, at a CAGR of 10.8, driven mainly by better access and speedier launches of new drugs in the country.

According to lead analyst of this report; “The solid tumors treatment market is expected to show modest growth over the forecast period due to recent drug approvals and expected product launches for ovarian, pancreatic and prostate cancers. These new approvals, which have occurred in the last two years, have the potential to influence disease treatment patterns and may therefore have an effect on market size.”

With the Chinese government’s ambitious plans for healthcare reforms, access to healthcare facilities and drugs is expected to increase in the coming decade, which could be a major driver for the solid tumors market, although pricing regulation in China and India could restrict potential growth.

“In recent years, several attempts were made by the pricing and regulatory bodies in both India and China to improve access and affordability of innovative drugs. In late 2012, Indian government approved regulations to cap prices of 348 drugs on the Essential Drugs List (EDL). Additionally, manufacturers are required to price their drugs below the ceiling price, which is fixed by taking an average cost of all drugs that have more than 1% market share,” says Vulapalli.

However, a number of recent drugs have been approved in Australia and Japan, including Afinitor, Avastin, Jevtana, Sutent and Zytiga, which could trigger a shift in the treatment paradigm in the foreseen future.

This report analyzes treatment usage patterns, market characterization, pipeline analysis and key licensing and co-development deals in the bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer in the four APAC markets of Australia, China, India and Japan.

Spanning over 111 pages, 27 tables and 37 figures, “Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the Solid Tumors Market in Asia Pacific to 2019 - Introduction, Therapeutic Landscape, Marketed Products, Pipeline Analysis,  Market Forecast, Deals and Strategic Consolidations.

Find all Medical Diseases market research reports under a single page.

MarketResearchReports.com: Japanese Market for Wound and Tissue Management, New Report Launched

The wound and tissue management market includes wound closure devices, moist dressings, antimicrobial dressings, interactive dressings, traditional dressings, hemostats, tissue sealants, anti-adhesion products and negative pressure wound therapy. Products can be divided into external, internal and combined wound management. This market is expected to be driven by the increasing aging population, rising rates of obesity and diabetes, as well as the increased device efficiency. This report details the expected growth rates, average selling prices (ASP) and market values of the interlinked segments mentioned above.

Summary of the following:

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for Japan.

Report Contents: Competitor Analysis Identified Strategic Opportunities Market Overview by Segment Trend Analysis by Segment Market Drivers & Limiters Mergers & Acquisitions Customer Feedback and Market Monitoring Main Segments Included: Wound Closure Market Advanced Dressings Market Tissue Sealant Market Hemostats Market Anti-Adhesion Market Negative Pressure Wound Therapy Market Traditional Dressings Market.

For more information visit: Japanese Market for Wound and Tissue Management

Spanning over 164 pages, figures and charts, “Japanese Market for Wound and Tissue Management” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the Executive summary, Research methodology, Japanese wound and tissue management market overview, Wound closure market, Advanced dressings market overview, Moist dressings market, Antimicrobial dressings market, Interactive dressings market, Tissue sealant market, Anti-adhesion market, Negative pressure wound therapy market, Appendix 1: Traditional dressings market, Appendix 2: Hemostats market, Abbreviations.

Find all Treatments market research reports under a single page.